Back to search

Switzerland· 57860007

Mircera 150 ug / 0.3 ml, Injektionslösung in einer Fertigspritze

A methoxy polyethylene glycol-epoetin beta product containing methoxy polyethylene glycol-epoetinum beta, registered in Switzerland by Roche Pharma (Schweiz) AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC B03XA03

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedMircera 150 ug / 0.3 ml, Injektionslö…ATCB03XA03REGISTER NO.57860007PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Methoxy polyethylene glycol-epoetin beta is registered in 12 of 19 countries.

Countries holding a registration under ATC B03XA03 (methoxy polyethylene glycol-epoetin beta), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Methoxy polyethylene glycol-epoetin beta · ATC B03XA03

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methoxy polyethylene glycol-epoetin beta costs, country by country.

Normalised to the WHO defined daily dose (4 mcg), so markets compare like for like.

  • Switzerland: $10.18 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Methoxy polyethylene glycol-epoetin beta · price per daily dose (4 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$10.18
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
methoxy polyethylene glycol-epoetinum beta
Manufacturer
Roche Pharma (Schweiz) AG
Country
Switzerland (CH)
ATC code
B03XA03
ATC class
Methoxy polyethylene glycol-epoetin beta
Defined daily dose
4 mcg, P
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680578600074
    Fertspr 1 Stk
    CHF 310.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fea7ca8f-285c-49ee-a557-996373ab4360
GET /v1/drugs/fea7ca8f-285c-49ee-a557-996373ab4360?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "methoxy polyethylene glycol-epoetinum beta 150 mcg",
  "valid_from": "2007-12-01",
  "limitations": "[{\"description\":\"Renale Anämie bei Niereninsuffizienz.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2007-01-01\"}]",
  "galenic_form": "Inj Lös 150 mcg/0.3 ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2007-12-01",
  "self_retention_pct": 10
}

See everything about methoxy polyethylene glycol-epoetin beta.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.